Author:
Hotta K.,Matsuo K.,Ueoka H.,Kiura K.,Tabata M.,Harita S.,Gemba K.,Yonei T.,Bessho A.,Tanimoto M.
Reference21 articles.
1. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung;Rusch;Cancer Res,1993
2. Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas;Volm;Br J Cancer,1998
3. Protein kinase inhibitors: the tyrosine-specific protein kinases;Lawrence;Pharmacol Ther,1998
4. A multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small cell lung cancer (The IDEAL 1 trial);Fukuoka;J Clin Oncol,2003
5. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial;Kris;JAMA,2003
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献